CXCR2 and neoplasm: Moreover, RETAAD tumor cells attracted PMN-MDSC in vitro and this attraction was significantly reduced when PMN-MDSC were treated with either SB265610 or SB225002, two specific inhibitors of CXCR2 (Figure 1I).